Video

U.S. sesame allergy prevalence estimated at 750,000


 

REPORTING FROM AAAAI 2019

– The estimated U.S. prevalence of sesame allergy appears to be at least 0.23% among both adults and children, roughly about 750,000 people, according to a recent, representative survey of more than 78,000 Americans, which shows sesame allergy apparently is common enough to prompt the Food and Drug Administration to require food labels that identify sesame as an ingredient or possible contaminant.

The sesame-allergy data also showed that sesame reactions were rated as having been severe by about a third of respondents, they caused about two-thirds of people who responded to sesame to go to an emergency department at least once (the highest rate for this outcome among all food allergies), and reactions had led to use of an epinephrine automated injector by about a quarter of people who responded to it, Christopher M. Warren said at the annual meeting of the American Academy of Allergy, Asthma, and Immunology.


These findings document the public health importance of sesame allergy, which seems widespread and often severe enough to warrant making sesame the ninth allergen to require specific food labeling, said Ruchi S. Gupta, MD, senior author of the study and a professor of pediatrics and medicine at Northwestern University in Chicago.


“It seems to rank up with other food allergens regarding reaction severity,” Dr. Gupta said in a video interview. In October 2018, the FDA requested information on sesame allergy so that its staff could consider adding sesame to its list of major food allergens. The eight current major food allergens that require specific labeling are: peanut, tree nuts, eggs, milk, fish, shellfish, wheat, and soy. The 0.23% prevalence of sesame among U.S. residents makes it more common than certain tree nuts, and so the prevalence numbers also seem to justify adding sesame to the FDA’s labeling list because 750,000 is “a lot of people,” she noted.

An established surveying group based at the University of Chicago ran the data collection, which received responses from 53,575 U.S. household including 40,443 adults and 38,408 children. Dr. Gupta and her associates recently published information on the methods of the survey and other findings it made about U.S. food allergy rates (JAMA Network Open. 2019 Jan 4. doi: 10.1001/jamanetworkopen.2018.5630). The descriptions people provided about their food allergy diagnoses, and the effects these allergies had, underwent detailed review by a panel of experts who decide whether or not the evidence for an allergy was “convincing.” The 0.23% prevalence rate reported for sesame represented people for whom this allergy was convincingly demonstrated, reflected a confirmed physician diagnosis, or both, and hence it was a conservative estimate, Dr. Gupta said.

Christopher M. Warren, University of Southern California, Los Angeles Mitchel L. Zoler/MDedge News

Christopher M. Warren

Another notable finding about sesame allergy was that 82% of the affected people also reported an allergy to at least one other major food allergen, most commonly peanut or tree nuts, reported Mr. Warren, who did this research while working with Dr. Gupta at Northwestern and is now a researcher at the University of Southern California in Los Angeles. The data also showed that sesame allergies exist across the age spectrum, with about a quarter of adults with a sesame allergy reporting that it did not appear until they were at least 18 years old.

Mr. Warren had no disclosures. Dr. Gupta has been a consultant to Aimmune, Before Brands, DBV Technologies, Kaleo, Mylan, and Pfizer, and she has received research funding from Aimmune, Mylan, the National Confectioners Association, Rho, and Thermo Fisher.

SOURCE: Chadha AS et al. AAAAI 2019, Abstract 615.

Recommended Reading

Socioeconomic status, race found to impact CPAP compliance
Clinician Reviews
Marijuana smoking is an independent risk factor for lung disease in HIV+
Clinician Reviews
Flu activity hits seasonal high
Clinician Reviews
ALA report: Federal and state actions to limit tobacco use fall short
Clinician Reviews
E-cig use reverses progress in reducing tobacco use in teens
Clinician Reviews
Adenovirus: More than just another viral illness
Clinician Reviews
Adult HIV patients should receive standard vaccinations, with caveats
Clinician Reviews
Venous thromboembolism risk elevated in ankylosing spondylitis patients
Clinician Reviews
Flu season showing its staying power
Clinician Reviews
Influenza activity continues to increase
Clinician Reviews